Full cohort |
Crude |
Step1*
|
Step2**
|
Step3***
|
|
Beta [95% CI] |
Beta [95% CI] |
Beta [95% CI] |
Beta
[95% CI] |
No Anxiety |
0 [Reference] |
0 [Reference] |
0 [Reference] |
0 [Reference] |
Week 17 |
-0.61 [-1.1, -0.13] |
-0.71 [-1.26,
-0.16] |
-0.66 [-1.2, -0.11] |
-0.5 [-1.07,
0.06] |
Week 30 |
-1.28 [-1.79, -0.77] |
-1.27 [-1.86,
-0.69] |
-1.16 [-1.74, -0.58] |
-0.94 [-1.54,
-0.34] |
Both |
-1.77 [-2.42, -1.13] |
-1.83 [-2.57,
-1.1] |
-1.72 [-2.44, -0.99] |
-1.43 [-2.19,
-0.68] |
Sample size |
88,596 |
72,769 |
72,769 |
69,192 |
Sibling cohort |
|
|
|
|
No Anxiety |
0 [Reference] |
0 [Reference] |
0 [Reference] |
0 [Reference] |
Week 17 |
0.14 [-1.22, 1.51] |
0.41 [-1.24, 2.05] |
0.55
[-1.09, 2.19] |
0.34 [-1.39, 2.08] |
Week 30 |
-1.32 [-2.74, 0.1] |
-1.45 [-3.18, 0.29] |
-1.32
[-3.06, 0.41] |
-1.39 [-3.22, 0.45] |
Both |
-1.08 [-2.91, 0.75] |
-1.08 [-3.31, 1.14] |
-0.89
[-3.12, 1.33] |
-1.08 [-3.42, 1.27] |
Sample size1
|
12,017 |
8,883 |
8,883 |
8,249 |